PTGS2 and neoplasm: In OC, NF-κB and COX-2 pathways are core pathways involved in the anti-inflammatory and anti-tumor activities of NSAIDs, including sulindac, which can effectively reduce the transcription of growth factors, chemokines, and proteases that are elevated in OC (Altinoz and Korkmaz, 2004).